Covidien Board Approves Separation of Pharmaceuticals Business
May 24, 2013 at 07:01 AM EDT
Covidien plc (NYSE: COV ), a leading global provider of healthcare products, today announced that its board of directors has approved the separation of the Pharmaceuticals business from
